Active Stocks
Thu Mar 28 2024 14:49:26
  1. Tata Steel share price
  2. 155.95 2.03%
  1. HDFC Bank share price
  2. 1,455.55 1.03%
  1. ITC share price
  2. 430.95 0.69%
  1. Power Grid Corporation Of India share price
  2. 278.75 2.84%
  1. State Bank Of India share price
  2. 756.00 2.99%
Business News/ Companies / Aurobindo Pharma gets USFDA approval for CNS drug
BackBack

Aurobindo Pharma gets USFDA approval for CNS drug

Aurobindo Pharma gets USFDA approval for CNS drug

Premium

New Delhi: Aurobindo Pharma on Monday said it has received US health regulator’s approval to manufacture and sell generic Divalproex Sodium Delayed-Release tablets, used in the treatment of central nervous system disorders, in the American market.

The company, which has received final approval from US Food and Drug Administration (USFDA), will soon launch the tablets in the strengths of 125mg, 250mg and 500mg in the US market, Aurobindo Pharma said in a statement.

According to IMS Health data, the product has a global market size of nearly $144 million for the twelve months ending September 2010.

The company’s product is the generic equivalent of Abbott Laboratories’ Depakote Delayed-Release Tablets and falls under the neurological (CNS) therapeutic category, it said.

The Hyderabad-based firm now has a total of 135 abbreviated new drug application (ANDA) approvals from USFDA, it added.

Shares of Aurobindo Pharma were on Monday trading at Rs197.55 on the Bombay Stock Exchange (BSE) in the late afternoon trade, up 1.28% from its previous close.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 25 Apr 2011, 01:21 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie